Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

Presentation TCT 2017

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? No, Based on HORIZONS-AMI, PLATO, PEGASUS, and Other Studies!

Presenter: John A. Bittl, Freek W.A. Verheugt, Gennaro Giustino

October 30, 2017

Presentation TCT 2014

Incidence and Impact of Acute Kidney Injury in Patients with Acute Coronary Syndromes Treated with CABG: Insights from ACUITY/HORIZONS-AMI

Presenter: Josephine Warren

September 16, 2014

News Conference News TCT 2014

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

September 14, 2014

Presentation TCT 2014

EUROMAX and HORIZONS-AMI: Core Results and Study Group Interpretation

Presenter: Eugene H. Blackstone, Gregg W. Stone, Ori Ben-Yehuda, Philippe Gabriel Steg

September 13, 2014

Presentation TCT 2014

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Presenter: Patrick W. Serruys, George D. Dangas

September 13, 2014

News Conference News TCT 2014

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

September 13, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

Presentation TCT 2013

Stents and Pharmacotherapy in STEMI: Anticipating HORIZONS-AMI II

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Presenter: Benoit Daneault, Philippe Genereux, Ajay Kirtane, Bernhard Witzenbichler, Giulio Guagliumi, Jean-Michel Paradis, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2013

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Presenter: A. Rene, Philippe Genereux, Michael Ezekowitz, Ajay Kirtane, Roxana Mehran, Gregg Stone

January 31, 2013

News Conference News TCT 2012

STEMI-RADIAL Radial PCI Bests Femoral in STEMI Patients

Caitlin E. Cox

October 26, 2012

Presentation TCT 2012

New VH-IVUS Insights from PROSPECT and HORIZONS-AMI

Presenter: Akiko Maehara

October 25, 2012

Presentation TCT 2012

Lessons from the HORIZONS-AMI and INFUSE-AMI Trials

Presenter: Helen Parise

October 24, 2012

Presentation TCT 2012

A View to Future Trials: HORIZONS-AMI II and Others

Presenter: Roxana Mehran

October 24, 2012

Presentation TCT 2012

Vignettes on Plaque Stability 1: Insights from the VH Registry and HORIZONS-AMI

Presenter: Akiko Maehara

October 23, 2012

Presentation TCT 2012

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

TCT-62. Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Presenter: A. Rene

October 23, 2012

Advertisement

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? No, Based on HORIZONS-AMI, PLATO, PEGASUS, and Other Studies!

Incidence and Impact of Acute Kidney Injury in Patients with Acute Coronary Syndromes Treated with CABG: Insights from ACUITY/HORIZONS-AMI

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

EUROMAX and HORIZONS-AMI: Core Results and Study Group Interpretation

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

Stents and Pharmacotherapy in STEMI: Anticipating HORIZONS-AMI II

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

STEMI-RADIAL Radial PCI Bests Femoral in STEMI Patients

New VH-IVUS Insights from PROSPECT and HORIZONS-AMI

Lessons from the HORIZONS-AMI and INFUSE-AMI Trials

A View to Future Trials: HORIZONS-AMI II and Others

Vignettes on Plaque Stability 1: Insights from the VH Registry and HORIZONS-AMI

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

TCT-62. Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content